References:
1. Coronavirus Disease 2019 (COVID-19) Situation Report 124. 2020;
https://www.who.int/docs/default-source/coronaviruse/situation-reports/20200523-covid-19-sitrep-124.pdf?sfvrsn=9626d639_2,
Accessed May 24, 2020.
2. Driggin E, Madhavan MV, Bikdeli B, Chuich T, Laracy J, Bondi-Zoccai
G, Brown TS, Nigoghossian C, Zidar DA, Haythe J, Brodie D, Beckman JA,
Kirtane AJ, Stone GW, Krumholz HM and Parikh SA. Cardiovascular
Considerations for Patients, Health Care Workers, and Health Systems
During the Coronavirus Disease 2019 (COVID-19) Pandemic. J Am Coll
Cardiol . 2020.
3. Colson P, Rolain JM, Lagier JC, Brouqui P and Raoult D. Chloroquine
and hydroxychloroquine as available weapons to fight COVID-19. Int
J Antimicrob Agents . 2020:105932.
4. Gao J, Tian Z and Yang X. Breakthrough: Chloroquine phosphate has
shown apparent efficacy in treatment of COVID-19 associated pneumonia in
clinical studies. Biosci Trends . 2020;14:72-73.
5. Gautret P, Lagier JC, Parola P, Hoang VT, Meddeb L, Mailhe M, Doudier
B, Courjon J, Giordanengo V, Vieira VE, Dupont HT, Honore S, Colson P,
Chabriere E, La Scola B, Rolain JM, Brouqui P and Raoult D.
Hydroxychloroquine and azithromycin as a treatment of COVID-19: results
of an open-label non-randomized clinical trial. Int J Antimicrob
Agents . 2020:105949.
6. Szekely Y LY, Shrkihe BA, Bruck H, Oster HS, Viskin S.
Chloroquine-induced torsade de pointes in a COVID-19 patient.Heart Rhythm . 2020.
7. Dower GE, Yakush A, Nazzal SB, Jutzy RV and Ruiz CE. Deriving the
12-lead electrocardiogram from four (EASI) electrodes. J
Electrocardiol . 1988;21 Suppl:S182-7.
8. Ehlert FA, Goldberger JJ, Rosenthal JE and Kadish AH. Relation
between QT and RR intervals during exercise testing in atrial
fibrillation. Am J Cardiol . 1992;70:332-8.
9. Bland JM and Altman DG. Statistical methods for assessing agreement
between two methods of clinical measurement. Lancet .
1986;1:307-10.
10. Cheung CC DB, Gibbs K, Laksma ZW, Krahn AD. Multi-lead QT Screening
is Necessary for QT measurement: Implications for Management of Patients
in the COVID-19 Era. JACC Clin Electrophysiol . 2020.
11. HRS COVID-19 Task Force Update: April 7, 2020. 2020.
12. Chang D, Saleh M, Gabriels J, Ismail H, Goldner B, Willner J,
Beldner S, Mitra R, John R and Epstein LM. Inpatient Use of Ambulatory
Telemetry Monitors for COVID-19 Patients Treated with Hydroxychloroquine
and/or Azithromycin. J Am Coll Cardiol . 2020.
13. Gabriels J, Saleh M, Chang D and Epstein LM. Inpatient use of mobile
continuous telemetry for COVID-19 patients treated with
hydroxychloroquine and azithromycin. HeartRhythm Case Rep . 2020.
14. Bekker CL, Noordergraaf F, Teerenstra S, Pop G and van den Bemt BJF.
Diagnostic accuracy of a single-lead portable ECG device for measuring
QTc prolongation. Ann Noninvasive Electrocardiol . 2020;25:e12683.
15. Janssen GH, Rijkenberg S and van der Voort PH. Validation of
continuous QTc measurement in critically ill patients. J
Electrocardiol . 2016;49:81-6.
16. Chenoweth JA, Hougham AM, Colby DK, Ford JB, Sandhu J, Albertson TE
and Sutter ME. Monitoring the corrected QT in the acute care setting: A
comparison of the 12lead ECG and bedside monitor. Am J Emerg Med .
2018;36:777-779.
17. Drew BJ, Adams MG, Pelter MM and Wung SF. ST segment monitoring with
a derived 12-lead electrocardiogram is superior to routine cardiac care
unit monitoring. Am J Crit Care . 1996;5:198-206.